Student Affairs

Professor MOK Chung Tong, Vincent

Admission - Assistant Dean

Professor, Department of Medicine and Therapeutics
Director of Master Programme in Stroke and Clinical Neurosciences

Admission - Assistant Dean

Professor MOK Chung Tong, Vincent

Department of Medicine and Therapeutics

Contact Information
Office : (852) 3505-2195
Email :

School / Department / Institute / Centre / Unit
Division of Neurology, Department of Medicine and Therapeutics
Associate Director (Neurosciences), Hong Kong Institute of Integrative Medicine
Executive Committee Member of Chow Yuk Ho Technology Center for Innovative Medicine
Executive Committee Member of Brain and Mind Institute

Neurology, Dementia, Movement Disorders 

MD (CUHK), FRCP (Edinburgh), FHKAM (Medicine), FHKCP, MRCP, MBBS (University of Sydney)

Research Interests
Vascular Cognitive Impairment, Cerebral Small Vessel Disease, Neuroimaging in Cognitive Impairment, Parkinson’s Disease

Additional Information
Service in Professional Societies:
President of the Chinese Dementia Research Association, (2014–Present)
Immediate Past-President of the Hong Kong Movement Disorder Society (2012–2014)
Hong Kong Representative to the World Federation of Neurology (2012–Present)
Executive Committee member of the International Society of Vascular Behavioral and Cognitive Disorders (2012–Present)
Honorary Treasurer of the Asian Society Against Dementia (2012– Present)

Selected Publications
  1. Liu W, Wong A, Law A.C.K., Mok V.C.T. Cerebrovascular Disease, Amyloid Plaques, and Dementia. Stroke 2015; 46: 1402-1407.
  2. Jie YANG, Adrian WONG, Zhaolu WANG, Wenyan LIU, Lisa AU, Yunyun XIONG, Winnie W.C. CHU, Eric Yim Lung LEUNG, Sirong CHEN, Christine LAU, Anne Y.Y. CHAN, Alexander Y.L. LAU, Florence FAN, Vincent IP, Yannie SOO, Thomas LEUNG, MD1; Chi Lai HO, Lawrence Ka Sing WONG, Vincent C.T. MOK.* Risk factors for incident dementia after stroke and transient ischemic attack. Alzheimer’s & Dementia 2014 March 3.
  3. Wang Z, Soo YO, Mok VC*. Cerebral Microbleeds: Is Antithrombotic Therapy Safe to Administer. Stroke 2014 Jul 15
  4. Mok V, Ding D, Fu Jianhui, Yunyun Xiong, Winnie W.C. Chu, Defeng Wang, Jill M Abrigo, Jie Yang, Adrian Wong, Qianhua Zhao, Qihao Guo, Zhen Hong, Ka Sing Wong. Transcranial Doppler Ultrasound for Screening Cerebral Small Vessel Disease – A Community Study. Stroke 2012 Oct; 43(10):2791-3.
  5. Mok V, Xiong Y, Wong KK, Wong A, Schmidt R, Chu WWC, Hu X, Leung EYL, Chen S, Chen Y, Tang WK, Chen X, Ho CL, Wong KS, Wong STC. Predictors for cognitive decline in patients with confluent white matter hyperintensities. Alzheimer's and Dementia 2012; May 30
  6. Wong A, Xiong YY, Wang D, Lin S, Chu WCW, Kwan P, Nyenhuis D, Black SE, Wong KSL, Mok V. The NINDS-Canadian Stroke Network Vascular Cognitive Impairment Neuropsychology Protocols in Chinese. Journal of Neurology, Neurosurgery and Psychiatry 2012 Dec 18.
  7. RA Hauser, M Cantillon, E E Pourcher, F Micheli, V Mok, M Onofri, S Huyck, K Wolski. Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial. Lancet Neurology 2011 Mar;10 (3):221-9
  8. V Mok, K Wong, Y Xiong, et al. Cortical and Frontal Atrophy are associated with Cognitive Impairment in Age-Related Confluent White Matter Lesion. Journal of Neurology Neurosurgery and Psychiatry 2010 Sep 8.
  9. V Mok, EYL Leung, W Chu, et al. Pittsburgh Compound B Binding in Poststroke Dementia. Journal of the Neurological Sciences 2010; 290 (1-2):135-7
  10. Mok V, Lam WWM, Fan YH, et al. Effects of Statins on the Progression of Cerebral White Matter Lesion: Post-hoc Analysis of the ROCAS (Regression of Cerebral Artery Stenosis) study. Journal of Neurology 2009;256(5):750-7
Director of Master Programme in Stroke and Clinical Neurosciences
Coordinator for Mentorship Programme for Global Physician Leadership Stream